Restenex

N/A

Report date: 2023/05/22 10:17:30

Base Information

Drug NameRestenex
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCalpain inhibitors
TargetsCalpain
Therapy Area/IndicationsVascular restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCortex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCortex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsVascular restenosis

Other Information

ATC CodeN/A
Related LinksN/A